GLUCOTROL XL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glucotrol Xl, and what generic alternatives are available?
Glucotrol Xl is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in GLUCOTROL XL is glipizide. There are eighteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the glipizide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glucotrol Xl
A generic version of GLUCOTROL XL was approved as glipizide by AUROBINDO PHARMA USA on May 10th, 1994.
Summary for GLUCOTROL XL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 14 |
Patent Applications: | 4,250 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GLUCOTROL XL |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GLUCOTROL XL |
What excipients (inactive ingredients) are in GLUCOTROL XL? | GLUCOTROL XL excipients list |
DailyMed Link: | GLUCOTROL XL at DailyMed |
![GLUCOTROL XL drug patent expirations Drug patent expirations by year for GLUCOTROL XL](/p/graph/s/t/GLUCOTROL_XL-patent-expirations.png)
![Drug Prices for GLUCOTROL XL](/p/graph/drug-price/GLUCOTROL+XL.png)
See drug prices for GLUCOTROL XL
![Drug Sales Revenue Trends for GLUCOTROL XL](/p/graph/drug-sales-revenues/GLUCOTROL+XL.png)
Recent Clinical Trials for GLUCOTROL XL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Baylor College of Medicine | Phase 4 |
Novartis | Phase 2 |
LanZhou University | N/A |
Pharmacology for GLUCOTROL XL
Drug Class | Sulfonylurea |
Anatomical Therapeutic Chemical (ATC) Classes for GLUCOTROL XL
US Patents and Regulatory Information for GLUCOTROL XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GLUCOTROL XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GLUCOTROL XL
See the table below for patents covering GLUCOTROL XL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2251183 | ⤷ Try a Trial | |
Ireland | 56515 | OSMOTIC DEVICE WITH DUAL THERMODYNAMIC ACTIVITY | ⤷ Try a Trial |
Switzerland | 669329 | ⤷ Try a Trial | |
Spain | 8503503 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |